Cat. #153421
H314 Cell Line
Cat. #: 153421
Unit size: 1x10^6 cells / vial
Availability: 10-12 weeks
Tissue: Oral Cavity
Disease: Cancer
Model: Tumourigenic cell line
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Stephen Prime
Institute: University of Bristol
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: H314 Cell Line
- Alternate name: H-314; h314; SCC-HN; HNSCC; HN-SCC
- Research fields: Cancer
- Tissue: Oral Cavity
- Disease: Cancer
- Growth properties: Adherent
- Model: Tumourigenic cell line
- Conditional: Yes
- Description: Established from a squamous cell carcinoma (SCC) of the floor of the mouth (20mm-40mm) of an 82 year-old male patient. STNMP stage II, moderately differentiated, node positive tumour. Mutant p53, codon 176 exon 5, G to T and 373 exon 11, A to G; wild type K-, N- and Ha-ras. Tumourigenic in athymic nude mice on subcutaneous injection; on injection into the floor of the mouth, cells spread to lymphatics and lymph nodes. By short tandem repeat (STR)-PCR analysis the Y chromosome could not be detected in this cell line when tested at ECACC. It is a known phenomenon that SSC cell lines can lose their Y chromosome. Explore more human oral SCC cell lines from the same inventor including: H157, H376, H357, H400 and H103.
- Cellosaurus id: CVCL_2460
Target Details
- Target: Human oral squamous cell carcinoma, floor of mouth
Handling
- Format: Frozen
- Growth medium: Split sub-confluent cultures (70-80%), approximately every 6-7 days, 1:8 to 1:10 using 0.25% trypsin/EDTA; 5% CO2; 37°C. Suggested seeding density 7 x 1000 cells/cm2. DMEM:HAMS F12 (1:1) + 2mM Glutamine + 10% Foetal Bovine Serum (FBS) + 0.5 ug/ml sodium hydrocortisone succinate.
- Unit size: 1x10^6 cells / vial
- Shipping conditions: Dry ice
References
- Yeudall et al. 1995. Eur J Cancer B Oral Oncol. 31B(2):136-143. PMID: 7633286.
- Prime et al. 1994. Int J Cancer. 56(3):406-412. PMID: 7508893.
- Prime et al. 1994. Br J Cancer. 69(1):8-15. PMID: 8286215.
- Yeudall et al. 1993. Eur J Cancer B Oral Oncol. 29B(1):63-67. PMID: 8180579.
- Prime et al. 1990. J Pathol. 160(3):259-269. PMID: 1692339.
